Composition having improved voluntary acceptance
A liquid drug formulation with hypoxia-inducible factor prolyl hydroxylase inhibitors and natural oils enhances palatability, addressing low acceptance issues and ensuring complete medication compliance in animals.
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- ELANCO ANIMAL HEALTH GMBH
- Filing Date
- 2026-01-21
- Publication Date
- 2026-06-04
AI Technical Summary
Existing oral drug formulations for animals, particularly those containing hypoxia-inducible factor prolyl hydroxylase inhibitors, face challenges with low acceptance and voluntary intake, especially in pets like cats and dogs, leading to incomplete medication and safety risks for owners during daily administration.
A liquid drug-containing formulation comprising a hypoxia-inducible factor prolyl hydroxylase inhibitor combined with natural oils of herbal and animal origin, optionally with a thickener, to enhance palatability and acceptance.
The formulation significantly improves voluntary drug intake in animals over prolonged periods, ensuring complete medication compliance and owner safety by enhancing palatability and acceptance.
Smart Images

Figure US20260151401A1-C00001 
Figure US20260151401A1-C00002 
Figure US20260151401A1-C00003